Diabetes

A Stanford Medicine study identifies an easily measured biophysical property that can identify Type 2 diabetics at increased risk for liver cancer who don’t meet current screening guidelines.

A new study led by Stanford Medicine indicates that an AI app can help Type 2 diabetic patients manage their blood glucose levels.

Stanford Medicine recently became the national center for a program to improve the diversity and increase the number of physician-scientists who are experts in Type 1 diabetes.

A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.

Diabetes treatment technology improved teenagers’ blood sugar levels and benefited their brain structure and function, according to a study led by Stanford Medicine researchers.

In a trial of the two low-carb diets, both were similarly effective in controlling blood glucose. Keto’s more severe carb restrictions did not provide additional overall health benefits.

In men, the use of metformin may affect sperm development in a way that increases birth defects in their sons, a study found.

About 1 in 3 American adults has insulin resistance, a silent time bomb that doubles their risk for serious depression, Stanford scientists have learned.

A three-year trial of a multifaceted intervention for managing obesity in low-income, Latino children showed promising results over two years.

Pancreatic alpha cells from people with diabetes release excess amounts of glucagon, a hormone important in blood sugar control, in a new Stanford-developed mouse model of transplanted human islets.

Pioglitazone, available generically for treating Type 2 diabetes, improved symptoms of long-term depression in patients also suffering from insulin resistance.